A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Clinical trial NCT05930028 · COMPLETED
Trial details
- NCT number
- NCT05930028
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-13
- Primary completion
- 2024-09-05
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.